Advertisement

Radiopharmaceuticals for Imaging Infectious and Inflammatory Foci

  • Peter H. Cox
Part of the Developments in Nuclear Medicine book series (DNUM, volume 31)

Abstract

It is well known that a number of radiopharmaceuticals show a non specific uptake in inflammatory processes. Whilst this may be of some diagnostic value there is a need for reagents which localise specifically in foci of inflammation and which distinguish between infection and aseptic inflammatory processes not to mention occult foci of infection and non specific tumour uptake. Such a requirement immediately introduces the concept that different classes of radiopharmaceutical will be required to distinguish these types of lesion from one another. Inflammatory foci do not have a specific receptor to which a potential radiopharmaceutical can be targeted but whilst the inflammatory process is a complicated phenomenon it does have a number of features which can positively influence the accumulation of radiopharmaceuticals in the lesion.

Keywords

Inflammatory Focus Indium Chloride Label Monoclonal Antibody Imaging Cerebral Blood Flow Label Leucocyte 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    van der Pompe W.B. An ionic model to explain the distribution of metal chelates in normal and pathological tissues. In: Progress in Radiopharmacology Ed: P.H. Cox. Elsevier North Holland. Amsterdam. [1979] 31–44.Google Scholar
  2. 2.
    Cox. P.H. The biological behaviour of Technetium complexes with particular reference to brain tumours. Progress in Radiopharmacology, pp 45–62.Google Scholar
  3. 3.
    Taylor D.M. and Hammersley P.A.G. Tumour localisation of Gallium in relation to DNA synthesis, transferrin and lysosomal enzyme activity. Progress in Radiopharmacology pp 63–73.Google Scholar
  4. 4.
    Hoffer P.B., Bekerman C. and Henkin R.E. Editors. In: Gallium-67 Imaging. John Wiley and Sons, New York.[1978] pp 1–9.Google Scholar
  5. 5.
    Hussein M.A.D. et al. Clinical experience with In-111 Indium Chloride scanning in inflammatory diseases. Clin Nucl Med [1978] 3.196–201.CrossRefGoogle Scholar
  6. 6.
    Iles S.E. et al. Indium-111 Chloride scintigraphy in osteomyelitis. J Nucl Med [1987].28.1540–1545.PubMedGoogle Scholar
  7. 7.
    Mountford P.J. et al. A study of leukocyte labelling efficiencies obtained with In-111 oxine. Nucl Med Comm [1985] 6.109–114.CrossRefGoogle Scholar
  8. 8.
    Thakur M.L. et al. In-111 labelled cellular blood components; mechanism of labelling and intracellular location in human neutrophils. J Nucl Med [1977] 18. 1020–1024.Google Scholar
  9. 9.
    Peters M.A. et al. Imaging of inflammation with Indium-111 tropolonate labelled leukocytes. J Nucl Med [1983] 24.39–44.PubMedGoogle Scholar
  10. 10.
    Danpure H.J. et al. The development of a clinical protocol for radiolabelling mixed leucocytes with Technetium-99m-hexamethylpropyleneamineoxine [HMPAO]. Nucl Med Comm [1988] 9.465–475.CrossRefGoogle Scholar
  11. 11.
    McAfee J.G. et al. 99m-Tc-HMPAO for leucocyte labelling experimental comparison with 111-In oxine in dogs. Eur J Nucl Med [1987] 13.353–357.PubMedCrossRefGoogle Scholar
  12. 12.
    Roddie M.E. et al. Imaging inflammation with 99m-Tc HMPAO labelled white cells. Nucl Med Comm [1987] 8.285.Google Scholar
  13. 13.
    English D. and Andersen B.R. Labelling of phagocytes from human blood with Technetium-99m sulphur colloid. J Nucl Med [1975] 16.5–10.PubMedGoogle Scholar
  14. 14.
    Mock B.H. and English D. Leukocyte labelling with Technetium-99m Tin colloids. J Nucl Med [1987] 28.1471–1477.PubMedGoogle Scholar
  15. 15.
    De Schrijver M. Scintigraphy of inflammation with nanometer sized colloidal tracers. Kluwer Academic Publishers, Dordrecht. [1989]CrossRefGoogle Scholar
  16. 16.
    Beaumier P.L. and Hwang K.J. Efficient method for loading Indium-111 into liposomes using acetylacetone. J Nucl Med [1982] 23.810–815.PubMedGoogle Scholar
  17. 17.
    Goins B. et al. Biodistribution and imaging studies of Technetium-99m labelled liposomes in rats with focal infection. J Nucl Med [1993] 34.2160–2168.PubMedGoogle Scholar
  18. 18.
    Boerman O.C. et al. Tc-99m labelled PEG Liposomes to image infection: Effect of particle size and comparison with Tc-99m labelled leucocytes. Eur J Nucl Med [1996]. 239.1068.Google Scholar
  19. 19.
    Locher J.T. et al. Imaging of inflammatory and infectious lesions after injection of radioiodinated monoclonal anti granulocyte antibodies. Nucl Med Comm [1986] 7.659–670.Google Scholar
  20. 20.
    Joseph K et al. In vivo labelling of granulocytes using Technetium-99m labelled monoclonal antibodies: First clinical results. Nu Comp.[1987] 18.223–229.Google Scholar
  21. 21.
    Becker W. et al. Kinetic data of in vivo labelled granulocytes in humans with murine Technetium-99m labelled monoclonal antibody. Eur J Nucl Med [1989] 15. 3611-366.Google Scholar
  22. 22.
    Goldenberg D.M. et al. Use of Leukoscan an antigranulocyte antibody fragment in the evaluation of patients with acute non classic appendicitis. Eur J Nucl Med [1997].24.8Google Scholar
  23. 23.
    Gratz S. et al. 99mTc labelled Anti-SSEAl murine IGM monoclonal antibodies for imaging infection. Eur J Nucl Med [1996] 239.1067.Google Scholar
  24. 24.
    Rusckowski M. et al. Localisation of infection using streptavidin and biotin; an alternative to non specific polyclonal immunoglobulin. J Nucl Med [1992] 33.1810–1815.PubMedGoogle Scholar
  25. 25.
    Keelan E.T.M. et al. Imaging vascular endothelial activation: An approach using radiolabelled monoclonal antibodies against the endothelial cell adhesion molecule E-Selectin. J Nucl Med [1994] 35.276–281.PubMedGoogle Scholar
  26. 26.
    van der Laken C.J. et al. Specific targetting of infectious foci with radioiodinated human recombinant Interleukinl in an experimental model. Eur J Nucl Med [1995] 22.1249–1255.PubMedCrossRefGoogle Scholar
  27. 27.
    Babich J.W. et al. Technetium-99m labelled hydrazino nicotinamide derivatized chemotactic peptide analogues forimaging focalsites of bacterial infection. J Nucl Med [1993] 34.1964–1974.PubMedGoogle Scholar
  28. 28.
    Rubin R.H. et al. In-111 labelled non specific immunoglobulin scanning in the detection of focal infection. N Engl J Med [1989] 231.935–940.CrossRefGoogle Scholar
  29. 29.
    Technescan HIG Summary of Product Characteristics. Mallinckrodt Medical. DRN 4369 [1990].Google Scholar
  30. 30.
    Dams E.T.M. et al. Technetium-99m labelled to human immunoglobulin G via the nicotinyl hydrazine derivative [hynic]: first clinical results. Eur J Nucl Med [1996] 239.1068.Google Scholar
  31. 31.
    Rubin R.H. et al. Specific and non specific imaging of localised Fischer Immunotype 1 Pseudomonas Aeruginosa infection with radiolabelled monoclonal antibody. J Nucl Med [1988] 29.651–656.PubMedGoogle Scholar
  32. 32.
    Vinjamuri S. et al. Comparison of Tc-99m Infecton imaging with radiolabelled white cell imaging in the evaluation of bacterial infection. Lancet [1996].347.233–235.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1998

Authors and Affiliations

  • Peter H. Cox

There are no affiliations available

Personalised recommendations